SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech fireworks
An SI Board Since October 2001
Posts SubjectMarks Bans
7424 222 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
5174DCGN 150%. Aren't they bust ?nigel bates-12/16/2009
5173UPDATE 1-Achillion shares surge on hepatitis C drug data * Analysts say efficactnsaf-12/16/2009
5172ARRY up about a quarter on last night's partnership news.nigel bates-12/15/2009
5171Active Biotech up 17% this morning on preliminary P2 results from their selectivnigel bates-12/15/2009
5170OT - BiolineRX As far as I know Dr. Laster, who is a nice and reliable guy imo, idos-12/14/2009
5169OT- That was the rumor I heard but when someone leaves a key position without mukenhott-12/13/2009
5168>Do you have a guess why Laster left? I understand he wasn't happy< idos-12/11/2009
5167(SNSS) Up another 30% or so today. Stock offering on the way ?nigel bates-12/11/2009
5166Minnow CYCC, 40%. "Skymark Research Initiates Independent Research Coveragnigel bates-12/11/2009
5165OT-Well Wilder, sounds like we have someone else who is going to do the rowing..kenhott-12/11/2009
5164By my count there's about 230M fd shares outstanding for SNSS. FWIW.rkrw-12/10/2009
5163Ken and Wilder, I doubt very much the ICI meeting had anything to do with Biolinidos-12/10/2009
5162SNSS up another 60%, on further puffing of the Voreloxin Phase 2 data.nigel bates-12/10/2009
5161With you as lookout (look out?) I will pull with all my strength for you are indkeokalani'nui-12/10/2009
5160Bioline price has been down the last couple of days, high 4s to high 3s. Back ukenhott-12/10/2009
5159SNSS was up 20% on voreloxin data presented at ASH and plans for an end-of-phaseidos-12/9/2009
5158TRGT now near firesale.nigel bates-12/3/2009
5157TRGT premarket on the AZN licensing deal. "...Under the agreement, AstraZenigel bates-12/3/2009
5156GERN also ran on this on very high volume. Also ASTM moved a little. finance.yaRockyBalboa-12/2/2009
5155STEM up a third, presumably because of this ? By LAURAN NEERGAARD, AP Medical Wnigel bates-12/2/2009
5154OPXA +50 % Don't know if this is why: Opexa Therapeutics Inc. (OPXA, $2.84, sjemmeri-12/2/2009
5153SNTS on FDA's approval of Zegerid finance.yahoo.com BernardJibacoa-12/2/2009
5152DYAX up about a third, premarket. Message 26143670nigel bates-12/2/2009
5151CYTX +15%, closed +13% on 4X ADV, possibly anticipating presentation mentioned itnsaf-11/30/2009
5150Lupus drug, HGSI out in the news, people looking. Volume not above average.kenhott-11/30/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News